Nifty
:
25571.25
Sensex
:
82814.71
116.90 (0.46%)
316.57 (0.38%)
Nifty
Sensex
:
:
25571.25
82814.71
116.90 (0.46%)
316.57 (0.38%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :
58/99

BSE: 532300 | NSE: WOCKPHARMA

NSE BSE
1381.60
20-Feb-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1382.4
  •  1394
  •  1375.2
  •  1392.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  180341
  •  249664709.3
  •  1868.8
  •  1110.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 22,435.29
  • 1019.79
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 24,524.29
  • N/A
  • 4.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.08%
  • 2.62%
  • 26.52%
  • FII
  • DII
  • Others
  • 7%
  • 8.09%
  • 6.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.83
  • 2.15
  • 4.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.27
  • -
  • 31.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -30.93
  • -56.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.27
  • 2.62
  • 3.54

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 58.40
  • 48.31
  • 57.38

Earnings Forecasts:

(Updated: 14-02-2026)
Description
2024
2025
2026
2027
Adj EPS
-3.02
P/E Ratio
-457.48
Revenue
2915
EBITDA
393
Net Income
-47
ROA
-0.6
P/B Ratio
5.16
ROE
-1.22
FCFF
-264
FCFF Yield
-1.08
Net Debt
1342
BVPS
267.9

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
888.00
721.00
23.16%
782.00
809.00
-3.34%
738.00
739.00
-0.14%
743.00
700.00
6.14%
Expenses
711.00
593.00
19.90%
604.00
699.00
-13.59%
666.00
648.00
2.78%
679.00
803.00
-15.44%
EBITDA
177.00
128.00
38.28%
178.00
110.00
61.82%
72.00
91.00
-20.88%
64.00
-103.00
-
EBIDTM
19.93%
17.75%
22.76%
13.60%
9.76%
12.31%
8.61%
-14.71%
Other Income
25.00
8.00
212.50%
21.00
9.00
133.33%
20.00
30.00
-33.33%
15.00
54.00
-72.22%
Interest
60.00
60.00
0.00%
55.00
73.00
-24.66%
48.00
73.00
-34.25%
48.00
73.00
-34.25%
Depreciation
65.00
55.00
18.18%
53.00
55.00
-3.64%
56.00
54.00
3.70%
53.00
58.00
-8.62%
PBT
67.00
21.00
219.05%
91.00
-9.00
-
-109.00
-6.00
-
-22.00
-180.00
-
Tax
6.00
1.00
500.00%
9.00
7.00
28.57%
-1.00
10.00
-
23.00
-3.00
-
PAT
61.00
20.00
205.00%
82.00
-16.00
-
-108.00
-16.00
-
-45.00
-177.00
-
PATM
6.87%
2.77%
10.49%
-1.98%
-14.63%
-2.17%
-6.06%
-25.29%
EPS
3.64
0.86
323.26%
4.81
-1.43
-
-5.56
-0.91
-
-1.54
-10.97
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
3,151.00
3,012.00
2,798.00
2,651.00
3,230.00
2,708.00
2,843.99
3,565.84
3,936.90
4,014.61
4,453.22
Net Sales Growth
6.13%
7.65%
5.55%
-17.93%
19.28%
-4.78%
-20.24%
-9.43%
-1.94%
-9.85%
 
Cost Of Goods Sold
1,074.00
1,132.00
1,165.00
1,111.00
1,267.00
1,135.00
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
Gross Profit
2,077.00
1,880.00
1,633.00
1,540.00
1,963.00
1,573.00
1,640.54
1,929.53
2,139.37
2,352.54
2,839.54
GP Margin
65.92%
62.42%
58.36%
58.09%
60.77%
58.09%
57.68%
54.11%
54.34%
58.60%
63.76%
Total Expenditure
2,660.00
2,619.00
2,759.00
2,550.00
2,932.00
2,771.00
2,746.23
3,604.32
3,992.33
4,001.81
3,958.98
Power & Fuel Cost
-
113.00
107.00
103.00
98.00
82.00
85.41
93.30
77.80
110.10
113.99
% Of Sales
-
3.75%
3.82%
3.89%
3.03%
3.03%
3.00%
2.62%
1.98%
2.74%
2.56%
Employee Cost
-
651.00
629.00
637.00
749.00
763.00
743.33
800.38
937.06
966.51
950.77
% Of Sales
-
21.61%
22.48%
24.03%
23.19%
28.18%
26.14%
22.45%
23.80%
24.07%
21.35%
Manufacturing Exp.
-
170.00
142.00
126.00
169.00
145.00
120.90
153.76
135.27
179.40
252.14
% Of Sales
-
5.64%
5.08%
4.75%
5.23%
5.35%
4.25%
4.31%
3.44%
4.47%
5.66%
General & Admin Exp.
-
196.00
190.00
192.00
224.00
251.00
186.55
380.13
476.66
504.43
405.85
% Of Sales
-
6.51%
6.79%
7.24%
6.93%
9.27%
6.56%
10.66%
12.11%
12.56%
9.11%
Selling & Distn. Exp.
-
137.00
125.00
134.00
180.00
132.00
141.18
176.22
208.89
205.30
241.11
% Of Sales
-
4.55%
4.47%
5.05%
5.57%
4.87%
4.96%
4.94%
5.31%
5.11%
5.41%
Miscellaneous Exp.
-
220.00
401.00
247.00
245.00
263.00
265.41
364.22
359.12
374.00
241.11
% Of Sales
-
7.30%
14.33%
9.32%
7.59%
9.71%
9.33%
10.21%
9.12%
9.32%
8.57%
EBITDA
491.00
393.00
39.00
101.00
298.00
-63.00
97.76
-38.48
-55.43
12.80
494.24
EBITDA Margin
15.58%
13.05%
1.39%
3.81%
9.23%
-2.33%
3.44%
-1.08%
-1.41%
0.32%
11.10%
Other Income
81.00
62.00
83.00
122.00
20.00
132.00
60.08
21.02
177.49
114.25
66.10
Interest
211.00
254.00
305.00
302.00
299.00
249.00
275.74
265.14
255.49
225.27
128.96
Depreciation
227.00
217.00
223.00
251.00
247.00
246.00
224.14
163.95
149.53
148.93
141.91
PBT
27.00
-16.00
-406.00
-330.00
-228.00
-426.00
-342.04
-446.55
-282.96
-247.15
289.47
Tax
37.00
41.00
52.00
-3.00
-132.00
-271.00
-204.09
-134.76
25.70
-21.11
37.88
Tax Rate
137.04%
-256.25%
-12.38%
0.48%
32.12%
47.71%
59.67%
30.18%
-4.01%
8.54%
13.09%
PAT
-10.00
-47.00
-463.00
-559.00
-244.00
-299.00
-163.78
-289.66
-608.30
-195.72
250.08
PAT before Minority Interest
22.00
-57.00
-472.00
-621.00
-279.00
-297.00
-137.95
-311.79
-666.85
-226.04
251.59
Minority Interest
32.00
10.00
9.00
62.00
35.00
-2.00
-25.83
22.13
58.55
30.32
-1.51
PAT Margin
-0.32%
-1.56%
-16.55%
-21.09%
-7.55%
-11.04%
-5.76%
-8.12%
-15.45%
-4.88%
5.62%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-0.62
-2.89
-28.49
-34.40
-15.02
-18.40
-10.08
-17.83
-37.43
-12.04
15.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
4,352.00
3,359.00
3,354.00
3,849.00
3,376.00
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
Share Capital
81.00
77.00
72.00
72.00
55.00
55.37
55.34
55.32
55.27
55.25
Total Reserves
4,260.00
3,269.00
3,266.00
3,759.00
3,293.00
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
Non-Current Liabilities
887.00
617.00
-22.00
261.00
496.00
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
Secured Loans
274.00
0.00
222.00
260.00
500.00
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
Unsecured Loans
937.00
891.00
2.00
95.00
3.00
3.46
238.22
5.27
303.16
273.26
Long Term Provisions
29.00
28.00
26.00
32.00
84.00
45.60
53.48
64.89
94.23
70.74
Current Liabilities
2,043.00
2,791.00
3,435.00
3,207.00
3,121.00
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
Trade Payables
592.00
766.00
867.00
921.00
696.00
895.27
840.24
601.78
533.81
637.69
Other Current Liabilities
887.00
1,144.00
1,172.00
1,197.00
1,230.00
1,568.44
1,353.09
1,548.13
690.13
621.23
Short Term Borrowings
496.00
832.00
1,330.00
1,034.00
1,066.00
903.86
561.71
437.09
662.80
550.03
Short Term Provisions
68.00
49.00
66.00
55.00
129.00
129.61
108.62
104.71
92.07
32.90
Total Liabilities
7,586.00
7,070.00
7,075.00
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
Net Block
2,736.00
2,881.00
3,042.00
3,462.00
3,343.00
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
Gross Block
5,814.00
5,721.00
5,696.00
6,019.00
5,656.00
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
Accumulated Depreciation
3,078.00
2,840.00
2,654.00
2,557.00
2,313.00
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
Non Current Assets
5,017.00
4,886.00
4,867.00
5,081.00
4,951.00
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
Capital Work in Progress
2,033.00
1,722.00
1,539.00
1,342.00
1,379.00
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.45
0.45
0.45
0.45
0.45
Long Term Loans & Adv.
246.00
266.00
269.00
259.00
228.00
230.63
251.13
274.93
295.15
175.46
Other Non Current Assets
2.00
17.00
17.00
18.00
1.00
1.76
1.40
2.97
1.47
3.28
Current Assets
2,465.00
2,073.00
1,914.00
2,445.00
2,281.00
2,400.54
2,814.65
3,379.60
4,535.27
3,951.85
Current Investments
422.00
0.00
0.00
0.00
0.00
0.00
0.00
213.25
562.27
0.00
Inventories
725.00
640.00
658.00
769.00
799.00
716.20
819.36
855.71
1,107.95
1,102.16
Sundry Debtors
661.00
618.00
797.00
918.00
918.00
1,242.69
1,273.90
962.45
1,034.45
1,111.42
Cash & Bank
191.00
529.00
124.00
406.00
292.00
268.46
448.65
1,082.25
1,603.61
1,478.11
Other Current Assets
466.00
0.00
0.00
0.00
272.00
173.19
272.74
265.94
226.99
260.16
Short Term Loans & Adv.
466.00
286.00
335.00
352.00
272.00
172.21
272.74
265.94
197.75
260.16
Net Current Assets
422.00
-718.00
-1,521.00
-762.00
-840.00
-1,096.64
-49.01
687.89
2,556.46
2,110.00
Total Assets
7,482.00
6,959.00
6,781.00
7,526.00
7,232.00
7,720.20
7,571.04
7,978.48
8,848.84
7,975.79

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-22.00
219.00
153.00
413.00
-287.00
648.96
183.32
68.44
-269.47
71.61
PBT
-16.00
-420.00
-624.00
-411.00
916.00
-196.68
-300.32
-641.15
-247.15
357.01
Adjustment
455.00
677.00
635.00
554.00
-943.00
483.23
444.52
448.78
303.04
201.29
Changes in Working Capital
-492.00
-8.00
153.00
367.00
-143.00
379.58
80.29
278.33
-297.39
-402.76
Cash after chg. in Working capital
-53.00
249.00
164.00
510.00
-170.00
666.13
224.49
85.96
-241.50
155.54
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
31.00
-30.00
-11.00
-97.00
-117.00
-17.17
-41.17
-17.52
-27.97
-83.93
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-783.00
-137.00
-125.00
-201.00
1,470.00
-155.53
94.57
630.24
-686.64
-818.19
Net Fixed Assets
-411.00
-1.00
31.00
-416.00
-200.42
-499.84
-39.00
-45.55
-166.75
-368.17
Net Investments
-422.00
0.00
0.00
0.00
0.27
0.00
-0.05
0.00
0.00
0.00
Others
50.00
-136.00
-156.00
215.00
1,670.15
344.31
133.62
675.79
-519.89
-450.02
Cash from Financing Activity
409.00
334.00
-315.00
-71.00
-1,171.00
-679.58
-776.45
-769.47
1,254.49
254.26
Net Cash Inflow / Outflow
-396.00
416.00
-287.00
141.00
12.00
-186.15
-498.56
-70.79
298.38
-492.32
Opening Cash & Equivalents
505.00
90.00
370.00
232.00
219.00
397.34
897.24
963.64
662.98
1,158.69
Closing Cash & Equivalent
112.00
505.00
90.00
370.00
232.00
219.34
397.34
897.24
963.64
664.64

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
267.96
217.27
231.81
266.04
280.48
238.55
238.75
254.47
298.51
339.05
ROA
-0.78%
-6.67%
-8.42%
-3.71%
-3.93%
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
ROE
-1.48%
-14.12%
-17.32%
-7.77%
-9.92%
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
ROCE
4.07%
-2.15%
-5.88%
-1.96%
-5.50%
1.32%
-0.56%
-5.47%
-0.31%
6.87%
Fixed Asset Turnover
0.67
0.63
0.73
0.88
0.75
0.52
0.70
0.70
0.82
1.00
Receivable days
60.36
71.63
73.25
65.29
85.04
138.12
98.15
92.57
97.55
75.93
Inventory Days
64.42
65.71
60.95
55.76
58.60
82.83
73.51
91.03
100.47
87.00
Payable days
218.94
255.81
293.71
232.91
255.87
129.66
86.65
67.29
64.08
64.54
Cash Conversion Cycle
-94.15
-118.47
-159.51
-111.86
-112.23
91.29
85.01
116.31
133.94
98.39
Total Debt/Equity
0.43
0.63
0.57
0.49
0.70
1.22
1.28
1.33
1.26
0.71
Interest Cover
0.94
-0.38
-1.07
-0.37
-1.28
0.29
-0.13
-1.51
-0.10
3.24

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Wockhardt - Quarterly Results
    11th Feb 2026, 00:00 AM

    Read More
  • Wockhardt’s consolidated net profit jumps over four-fold in Q3
    10th Feb 2026, 16:00 PM

    The consolidated total income of the company increased by 25.24% at Rs 913 crore for Q3FY26

    Read More
  • Wockhardt’s WCK 5222 gets Accelerated Assessment grant from European Medicines Agency
    31st Dec 2025, 15:20 PM

    WCK 5222 represents the first New Chemical Entity discovered and developed in India to be submitted for pan-European marketing authorisation

    Read More
  • Wockhardt’s NDA for Zaynich gets accepted by USFDA
    1st Dec 2025, 14:58 PM

    Zaynich has been granted Fast Track designation by the USFDA, recognizing its potential to address urgent and unmet medical needs

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.